231 related articles for article (PubMed ID: 28196832)
1. GPR55: a new promising target for metabolism?
Tudurí E; Imbernon M; Hernández-Bautista RJ; Tojo M; Fernø J; Diéguez C; Nogueiras R
J Mol Endocrinol; 2017 Apr; 58(3):R191-R202. PubMed ID: 28196832
[TBL] [Abstract][Full Text] [Related]
2. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
Nevalainen T; Irving AJ
Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
[TBL] [Abstract][Full Text] [Related]
3. GPR55: from orphan to metabolic regulator?
Liu B; Song S; Jones PM; Persaud SJ
Pharmacol Ther; 2015 Jan; 145():35-42. PubMed ID: 24972076
[TBL] [Abstract][Full Text] [Related]
4. Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
Kapur A; Zhao P; Sharir H; Bai Y; Caron MG; Barak LS; Abood ME
J Biol Chem; 2009 Oct; 284(43):29817-27. PubMed ID: 19723626
[TBL] [Abstract][Full Text] [Related]
5. Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors.
Imbernon M; Whyte L; Diaz-Arteaga A; Russell WR; Moreno NR; Vazquez MJ; Gonzalez CR; Díaz-Ruiz A; Lopez M; Malagón MM; Ross RA; Dieguez C; Nogueiras R
Mol Cell Endocrinol; 2014 Mar; 383(1-2):159-69. PubMed ID: 24378736
[TBL] [Abstract][Full Text] [Related]
6. What is the natural ligand of GPR55?
Okuno T; Yokomizo T
J Biochem; 2011 May; 149(5):495-7. PubMed ID: 21324983
[TBL] [Abstract][Full Text] [Related]
7. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
[TBL] [Abstract][Full Text] [Related]
8. Advances Towards The Discovery of GPR55 Ligands.
Morales P; Jagerovic N
Curr Med Chem; 2016; 23(20):2087-100. PubMed ID: 27109575
[TBL] [Abstract][Full Text] [Related]
9. GPR55 - a putative "type 3" cannabinoid receptor in inflammation.
Yang H; Zhou J; Lehmann C
J Basic Clin Physiol Pharmacol; 2016 May; 27(3):297-302. PubMed ID: 26669245
[TBL] [Abstract][Full Text] [Related]
10. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of GPR55, a putative cannabinoid receptor.
Sharir H; Abood ME
Pharmacol Ther; 2010 Jun; 126(3):301-13. PubMed ID: 20298715
[TBL] [Abstract][Full Text] [Related]
12. GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors.
Zhao P; Abood ME
Life Sci; 2013 Mar; 92(8-9):453-7. PubMed ID: 22820167
[TBL] [Abstract][Full Text] [Related]
13. GPR55 and the regulation of glucose homeostasis.
Tudurí E; López M; Diéguez C; Nadal A; Nogueiras R
Int J Biochem Cell Biol; 2017 Jul; 88():204-207. PubMed ID: 28457969
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.
Obara Y; Ueno S; Yanagihata Y; Nakahata N
PLoS One; 2011; 6(8):e24284. PubMed ID: 21904624
[TBL] [Abstract][Full Text] [Related]
15. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
[TBL] [Abstract][Full Text] [Related]
16. Ginseng Gintonin Contains Ligands for GPR40 and GPR55.
Cho YJ; Choi SH; Lee R; Hwang H; Rhim H; Cho IH; Kim HC; Lee JI; Hwang SH; Nah SY
Molecules; 2020 Mar; 25(5):. PubMed ID: 32121640
[TBL] [Abstract][Full Text] [Related]
17. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
[TBL] [Abstract][Full Text] [Related]
18. The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.
Moreno-Navarrete JM; Catalán V; Whyte L; Díaz-Arteaga A; Vázquez-Martínez R; Rotellar F; Guzmán R; Gómez-Ambrosi J; Pulido MR; Russell WR; Imbernón M; Ross RA; Malagón MM; Dieguez C; Fernández-Real JM; Frühbeck G; Nogueiras R
Diabetes; 2012 Feb; 61(2):281-91. PubMed ID: 22179809
[TBL] [Abstract][Full Text] [Related]
19. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
[TBL] [Abstract][Full Text] [Related]
20. The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55.
Kargl J; Balenga NA; Platzer W; Martini L; Whistler JL; Waldhoer M
Br J Pharmacol; 2012 Apr; 165(8):2611-9. PubMed ID: 21718301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
